Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long-term ...
MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...
ANX005-Treated Patients Demonstrated Faster and More Complete Recovery from Week 1 through Week 26 on Primary and Multiple Pre-Specified Endpoints Two and a Half Times More ANX005-Treated Patients ...
Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...
BRISBANE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...
In endemic areas, dengue-related Guillain-Barre syndrome could be a 'substantial and underrecognized component of the ...
LUND, Sweden, May 14, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG ...
Guillain Barre Syndrome (GBS), a post infectious neurological disease is spreading across Pune. With over 100 cases identified so far, it is important to know about the preventive measures. A ...
After multiple cases of Guillain-Barré Syndrome (GBS) were reported in Pune, Mumbai has now recorded its first case in 2025—a 64-year-old woman from Andheri West. Dr Daksha Shah, executive health ...
Add Yahoo as a preferred source to see more of our stories on Google. Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But when he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results